effect of Interfron-beta1(zifron) on clinical improvement and prognosis of COVID-19 in Tabriz Imam-Reza hospital

Phase 2

Recruiting

• Conditions: COVID-19 diseaese.; COVID-19, virus not identified; U07.2

• Registration Number: IRCT20200406046968N3
• Lead Sponsor: Zist Daru Danesh Company

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

respiratory rate> 24 / min
pao2 / Fio2< 300

Exclusion Criteria

Pregnancy
history of Sensitivity to interferon-beta 1 compounds (zifron)
History of advanced liver disease and liver enzymes three times normal
history of severe depression or suicidal thought

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oxygenation. Timepoint: daily. Method of measurement: pulse oximetery.

Secondary Outcome Measures

Name	Time	Method
P/F ratio. Timepoint: daily. Method of measurement: ABG.;Need for mechanical ventilation. Timepoint: daily. Method of measurement: file.;In hospital mortality. Timepoint: daily. Method of measurement: file.